A de novo mutation in the AGXT gene causing primary hyperoxaluria type 1

Area of Science:

• Genetics
• Biochemistry
• Pediatrics

Background:

• Primary hyperoxaluria type 1 (PH1) is an inherited metabolic disorder caused by mutations in the alanine-glyoxylate aminotransferase (AGXT) gene.
• Genetic testing, specifically linkage analysis, is often used to diagnose PH1 in siblings when direct mutation identification is challenging.
• Accurate diagnosis is crucial for timely management and to prevent severe complications like kidney failure.

Observation:

• A family was studied where linkage analysis suggested PH1 in a sibling, but subsequent biochemical tests over seven years did not confirm the diagnosis.
• Whole-gene sequencing of the index case revealed two causative AGXT mutations: one inherited and one de novo mutation (c.33_34insC).
• The de novo mutation, occurring in a cytosine-rich region, is a known cause of PH1 and may be prone to polymerase slippage.

Findings:

• Linkage analysis alone can be misleading in diagnosing PH1, highlighting the need for biochemical correlation.
• De novo mutations, although rare, are a significant consideration in the genetic etiology of PH1.
• The c.33_34insC mutation, identified as a de novo event, underscores the importance of comprehensive genetic analysis.

Implications:

• Biochemical confirmation is essential for all siblings diagnosed with PH1 via genetic testing.
• Clinicians should consider de novo AGXT mutations when evaluating suspected PH1 cases, especially when inherited mutations are not found.
• This case emphasizes the complexity of genetic diagnostics and the necessity of integrating multiple diagnostic approaches for rare diseases.